Can Stem Cell Treatment Benefit Stroke Recovery?
The novel treatment did not meet primary endpoints, however it did reduce hospitalization, adverse outcomes, and death.
The novel treatment did not meet primary endpoints, however it did reduce hospitalization, adverse outcomes, and death.
Women with pregnancy at an advanced age had significantly higher rates of ischemic stroke, hemorrhagic stroke, myocardial infarction, and cardiovascular death.
Patients of advanced age, black race, and with comorbidities have a higher risk of post-stroke GIBO.
The average annual cost for providing care to a stroke survivor was $11,300.
REVERSE-AD is an ongoing phase 3 cohort study evaluating the reversal effects of idarucizumab on dabigatran.
Treatment with IV tPA appeared safe and feasible with stroke onset confirmation from MRI.
Improvements in Rankin Scale score, Stroke Impact Scale-16, and Montreal Cognitive Assessment were observed in the treatment group.
Some strokes attributable to large-artery atherosclerosis are not being recognized as such because of <50% stenosis.
Those who slept more than 8 hours had a 146% greater risk of stroke.
Patients taking pioglitazone saw a 24% reduction in risk for recurrent stroke or myocardial infarction compared to placebo.